2036 / THE FUTURE BEYOND THE FUTURE
Early Detection + Preventive Medicine + AI
What if your most important medical appointment happened before you felt ill?
Healthcare could eventually become better at identifying specific problems early enough to prevent some of the harm they cause—without turning every healthy person into a patient.
THE BIG PICTURE / IN 30 SECONDS
Five ideas.
One extraordinary possibility.
2031
2036
- 01
Much of healthcare begins after something feels wrong. People develop symptoms, seek help and undergo tests, sometimes after a disease has already caused significant harm.
- 02
New sensors, blood tests and computational tools are revealing more about the body before symptoms appear. Some can identify specific risks or signs that deserve investigation, although the quality of the evidence varies enormously.
- 03
The challenge is learning which early signals actually matter. A test that detects an abnormal pattern isn't automatically useful; it must lead to a reliable decision that helps the person being tested.
- 04
If carefully validated tools become more accurate, prevention could become more personalized. Some people might receive a timely check or intervention based on a proven risk instead of waiting for the next standard appointment or obvious symptoms.
- 05
The extraordinary 2036 possibility is a partial reversal of healthcare's timetable. More resources could be used to prevent avoidable problems before people feel ill, provided the benefits outweigh false alarms, unnecessary treatment, cost and unequal access.
More than 142,000 participants—and a result that demands humility. England's major NHS-Galleri trial studied a blood test intended to help detect signs of multiple cancers before symptoms appeared. Results published in 2026 did not meet the trial's main goal of reducing overall late-stage cancer diagnoses. The result is not a failure of all preventive medicine; it is a vital demonstration that finding biological signals and improving health outcomes are two very different things.
THE BIGGER STORY: What changes when healthcare gets better at acting before illness has the chance to reshape a life?
THE FULL STORY / TODAY'S EVIDENCE, TOMORROW'S POSSIBILITIES
What happens when
the breakthroughs compound?
The extraordinary possibility: Healthcare could eventually become better at identifying specific problems early enough to prevent some of the harm they cause—without turning every healthy person into a patient.
Imagine the difference
Imagine a person feeling entirely well and receiving an unexpected recommendation from their healthcare team. A series of measurements—not an anonymous app notification—suggests that a particular, clinically established risk deserves closer attention. A follow-up test confirms a problem that can be treated early. The person avoids a more serious event later. The outcome is not a dramatic rescue in an emergency room, but a crisis that never happens.
That's the most compelling possibility of preventive healthcare. It also presents a frightening alternative: a future in which everyone receives constant warnings, many of which are wrong, while healthy people spend their time being investigated for conditions they may never develop. The same technology that could make medicine more proactive could also create a culture of anxiety and overdiagnosis.
The challenge is not collecting every possible piece of health data. It is identifying the few signals that deserve action, verifying them properly and proving that responding improves people's lives.
2026: Better signals do not automatically create better outcomes
Medical monitoring is already improving in specific fields. Devices can detect some irregular heart rhythms, routine screening finds certain cancers earlier, and genetic tests sometimes guide decisions for people at elevated risk. These are different tools with different evidence, and they should not be combined into one sweeping claim that predictive medicine has arrived.
The NHS-Galleri trial offers a powerful recent lesson. More than 142,000 volunteers in England took part in research on a blood test designed to detect signals associated with multiple cancers. The hope was that adding the test to screening could reduce diagnoses of advanced cancer. In 2026, investigators reported that the trial did not meet its main endpoint: the overall number of late-stage cancers, considered as stage 3 and 4 together, was not reduced. Some narrower results were encouraging, but they do not overturn the main finding.
That outcome should change how we talk about the future. A test can be scientifically sophisticated and still fail to improve the outcome it was designed to change. Early detection is useful only if it accurately identifies a meaningful problem and leads to an intervention whose benefits outweigh the harms. False positives can cause invasive follow-up procedures and anxiety; false negatives can create false reassurance.
Artificial intelligence might help interpret complex medical information, but it can also produce misleading patterns or recommendations. Real progress requires clinical evidence, not just impressive predictions.
2031: Prevention becomes more selective, not merely more frequent
Imagine a healthcare system five years from now where better-validated tools help identify which patients would benefit from particular screening or monitoring programs. Rather than sending everyone identical warnings, clinicians could combine medical history, established risk factors and reliable measurements to decide whether additional tests are justified. Some interventions might become possible earlier, and patients would receive a clearer explanation of what a result means—and what it doesn't.
This future would require more than technology. Clinicians need time to interpret findings, follow-up care must be available, and patients must be able to decline unnecessary testing. A new test that detects a possible problem is not useful if a person waits months to see a specialist or cannot afford the next step.
Data quality will be a major challenge. People from underserved populations must be adequately represented in research; otherwise tools could appear accurate while working poorly for particular groups. Health systems also need to measure outcomes over time instead of counting alerts, tests or app downloads.
2036: What if the most important result is what never happens?
By 2036, we could imagine a healthcare system in which some important conditions are intercepted earlier, when effective interventions are simpler or less disruptive. Preventive care might become more tailored to actual risk, particularly where long-term evidence demonstrates that a measurement changes a clinical decision in a useful way. It could also help people manage established chronic conditions more effectively and avoid preventable complications.
The economic consequences could be large. Preventing an avoidable hospitalization may be better for a person and potentially less costly than emergency care. But not every screening program saves money, and not every disease can be prevented. More testing can increase total spending and make healthcare less equitable if preventive tools are sold primarily to wealthy people.
The deeper social question is whether we could come to value a medical system that succeeds quietly. A hospital can count operations and admissions. A preventive system has to measure what did not occur—and prove that its intervention was responsible. That is statistically and ethically difficult.
The YottaBit future, then, is not a magical blood test revealing every possible disease. It is a more disciplined health system able to act at the right moment, for the right person, when there is good evidence that action helps.
IT GETS PERSONAL / FOUR DIMENSIONS OF CHANGE
What could this mean
for my future?
My life
There may be new opportunities for personalized prevention, but the most sensible approach remains grounded in validated screening, professional advice and one's actual health context. A future product should not be trusted simply because it claims to detect illness before symptoms. Ask what it measures, how often it is wrong, and what useful action follows a positive result.
My career
Medicine may create new roles combining clinical care, statistics, diagnostics, patient communication and responsible AI evaluation. The ability to explain uncertainty could become a particularly valuable skill. Patients will need trusted people who can help interpret a surprising result without either dismissing it or turning it into a catastrophe.
My business
Healthcare organizations and insurers considering preventive tools should demand evidence of better outcomes, not just earlier alerts. Employers offering wellness technologies should protect workers from intrusive monitoring or discrimination. Technology companies can create real value by helping clinical teams act appropriately on information rather than maximizing the number of notifications generated.
My industry and society
Prevention could change the relationship between clinics, laboratories, public health and communities. But the infrastructure for follow-up care must grow alongside detection. A society that can identify risk but cannot offer treatment has not solved the problem. Equal access and informed consent must be core requirements, not later enhancements.
JIM CARROLL'S PERSPECTIVE
The breakthrough is earlier action, not more data
Jim Carroll has spent decades describing the acceleration of healthcare science and personalized medicine, including his 2017 keynote for Genentech. The most valuable perspective here is that cheaper tests and more information can alter what medicine attempts—but only when the information supports a meaningful decision. More data isn't automatically better care.
A practical leadership question is: Which problem would be materially less harmful if we could identify it early, and is there already a validated intervention worth taking?
THE REALITY CHECK / WHAT MUST HAPPEN FIRST
What must happen before this future becomes real?
Clinical trials must show better patient outcomes, not merely higher detection rates. Follow-up care must be available; data must remain private; false alarms and overdiagnosis must be addressed; and health systems must avoid incentives that reward unnecessary testing. The NHS-Galleri results show why optimism without evidence would be irresponsible.
THE BIGGER YOTTABIT IDEA
The future is bigger
than you think.
The YottaBit possibility is not a world where everybody is constantly tested. It's a world where we can sometimes act sooner, with enough confidence that acting will actually help.
THE SCIENCE / CHECK THE EVIDENCE
Where the facts end
and the future begins.
The sources below support the present-day foundation of this story—not a promise that the 2031 or 2036 scenarios will happen. These are possibilities, not forecasts.
- NHS-Galleri trial, September 2026 publication update — Primary endpoint was not met.
- University College London Hospitals, first NHS-Galleri results, June 2026 — Clinical interpretation and limitations.
- NHS-Galleri, what the trial found — Explanations of test accuracy and follow-up.
- Jim Carroll: 2017 Genentech keynote, accelerating personalized medicine and exponential genomics; historical industry context.
THE NEXT FUTURE / KEEP EXPLORING